Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 3NIH 1NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 7Other solid neoplasm 5Genitourinary 3Sarcoma 2Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Breast 2Myeloid 1Classical hematology 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 4Unspecified Childhood Solid Tumor, Protocol Specific 1

Interventions

Cisplatin 70Paclitaxel 68pembrolizumab 65Carboplatin 61Irinotecan 59Injections 53Gemcitabine 53Docetaxel 49Fluorouracil 35Cyclophosphamide 35Pemetrexed 34Oxaliplatin 31Capecitabine 30Bevacizumab 29Leucovorin 27atezolizumab 23Nivolumab 23tislelizumab 19Etoposide 18Cetuximab 17durvalumab 16Temozolomide 16Bortezomib 16alvocidib 15Topotecan 15olaparib 14Sorafenib 14Rifampin 14Itraconazole 14Erlotinib Hydrochloride 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Immunologic Techniques × Other solid neoplasm × Clear all
NCT00504296 2023-08-04

SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Canadian Cancer Trials Group

Phase 1 Completed
39 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00909831 2019-04-16

Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
40 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00878904 2017-03-24

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors

University of California, San Francisco

Phase 1 Completed
40 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00436761 2013-12-18

Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

National Cancer Institute (NCI)

Phase 1 Unknown
20 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00376727 2010-03-29

Cetuximab in Treating Patients With Advanced Solid Tumors

University of California, Davis

Phase 1 Completed
27 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡